ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 01 May 2023
Last Applicant/ Owned by
3 Forbes Road
Lexington
MA
02421
Serial Number
90836060 filed on 19th Jul 2021
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
EVAMPLIX (BALSTILIMAB)
pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparatio Read More
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases
Mark Details
Serial Number
No 90836060
Mark Type
No Service/Collective Mark
Attorney Docket Number
No A09892003500
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.19.04 -
Cubes
Legal History
| Status Date | Action Taken |
|---|---|
| 01st May 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 01st May 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 27th Sep 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 02th Aug 2022 | PUBLISHED FOR OPPOSITION |
| 02th Aug 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 13th Jul 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 30th Jun 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 29th Jun 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 29th Jun 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 29th Jun 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |